Pangaea Ventures
Pangaea Ventures is a Vancouver-based venture capital firm founded in 2000 that provides early- to growth-stage funding for technology-driven and materials-intensive ventures. It concentrates on hard tech and advanced materials across energy, electronics, health, nanotechnology, chemistry, and cleantech, pursuing solutions in energy generation and storage, energy efficiency, and environmental materials. The firm backs companies addressing fundamental global challenges such as climate change, food and water security, and health outcomes, with a preference for commercial products and enabling technologies. It typically seeks significant minority stakes, aims to hold board representation, and positions itself as a lead investor while remaining open to co-investment. While headquartered in Vancouver, it operates with additional offices in Phoenix and Hillsborough and focuses on opportunities in North America and Europe. The firm emphasizes impact-oriented investing across incubation, startup, and growth phases, supporting portfolio companies through multiple growth stages.
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
Past deals in British Columbia
Aspect Biosystems
Series B in 2025
Aspect Biosystems Ltd. is a biotechnology company based in Vancouver, Canada, specializing in 3D bioprinting and tissue engineering. Founded in 2013, the company leverages proprietary microfluidic 3D bioprinting technology to develop bioprinted tissue therapeutics aimed at transforming disease treatment. By integrating therapeutic cells and materials science, Aspect Biosystems creates allogeneic cell-based tissue therapeutics that can replace or repair damaged organ functions. The company also provides a Lab-on-a-printer technology that allows precise control over biomaterial composition and structure during tissue fabrication. Its innovative platform supports the development of novel therapeutics and enhances understanding in fundamental biology and disease research, catering to pharmaceutical firms and academic institutions focused on respiratory diseases and regenerative medicine. Aspect Biosystems is actively collaborating with researchers and industry leaders to address significant challenges in the field of regenerative medicine.
Aspect Biosystems
Series A in 2020
Aspect Biosystems Ltd. is a biotechnology company based in Vancouver, Canada, specializing in 3D bioprinting and tissue engineering. Founded in 2013, the company leverages proprietary microfluidic 3D bioprinting technology to develop bioprinted tissue therapeutics aimed at transforming disease treatment. By integrating therapeutic cells and materials science, Aspect Biosystems creates allogeneic cell-based tissue therapeutics that can replace or repair damaged organ functions. The company also provides a Lab-on-a-printer technology that allows precise control over biomaterial composition and structure during tissue fabrication. Its innovative platform supports the development of novel therapeutics and enhances understanding in fundamental biology and disease research, catering to pharmaceutical firms and academic institutions focused on respiratory diseases and regenerative medicine. Aspect Biosystems is actively collaborating with researchers and industry leaders to address significant challenges in the field of regenerative medicine.
Aspect Biosystems
Venture Round in 2017
Aspect Biosystems Ltd. is a biotechnology company based in Vancouver, Canada, specializing in 3D bioprinting and tissue engineering. Founded in 2013, the company leverages proprietary microfluidic 3D bioprinting technology to develop bioprinted tissue therapeutics aimed at transforming disease treatment. By integrating therapeutic cells and materials science, Aspect Biosystems creates allogeneic cell-based tissue therapeutics that can replace or repair damaged organ functions. The company also provides a Lab-on-a-printer technology that allows precise control over biomaterial composition and structure during tissue fabrication. Its innovative platform supports the development of novel therapeutics and enhances understanding in fundamental biology and disease research, catering to pharmaceutical firms and academic institutions focused on respiratory diseases and regenerative medicine. Aspect Biosystems is actively collaborating with researchers and industry leaders to address significant challenges in the field of regenerative medicine.
Switch Materials
Series C in 2015
SWITCH Materials Inc. is a Canadian company founded in 2007, specializing in advanced materials that enable innovative smart window solutions for automotive applications, particularly for OEMs and Tier 1 suppliers. The company focuses on developing proprietary organic molecules that can switch optical properties on command, allowing for functionalities such as automatic darkening of sunroofs in sunlight to reduce heat and glare. Their technology integrates seamlessly into various applications, including automotive glass, architectural glass, and eyewear. SWITCH Materials also conducts extensive research and development in its laboratories and at Simon Fraser University’s 4D LABS, leveraging the expertise of materials scientists skilled in synthetic chemistry, polymer processing, and optics. The company aims to contribute to lower emissions and enhanced customer experiences in electric vehicle markets, as well as in custom solar management applications.
Switch Materials
Series B in 2010
SWITCH Materials Inc. is a Canadian company founded in 2007, specializing in advanced materials that enable innovative smart window solutions for automotive applications, particularly for OEMs and Tier 1 suppliers. The company focuses on developing proprietary organic molecules that can switch optical properties on command, allowing for functionalities such as automatic darkening of sunroofs in sunlight to reduce heat and glare. Their technology integrates seamlessly into various applications, including automotive glass, architectural glass, and eyewear. SWITCH Materials also conducts extensive research and development in its laboratories and at Simon Fraser University’s 4D LABS, leveraging the expertise of materials scientists skilled in synthetic chemistry, polymer processing, and optics. The company aims to contribute to lower emissions and enhanced customer experiences in electric vehicle markets, as well as in custom solar management applications.
Switch Materials
Venture Round in 2007
SWITCH Materials Inc. is a Canadian company founded in 2007, specializing in advanced materials that enable innovative smart window solutions for automotive applications, particularly for OEMs and Tier 1 suppliers. The company focuses on developing proprietary organic molecules that can switch optical properties on command, allowing for functionalities such as automatic darkening of sunroofs in sunlight to reduce heat and glare. Their technology integrates seamlessly into various applications, including automotive glass, architectural glass, and eyewear. SWITCH Materials also conducts extensive research and development in its laboratories and at Simon Fraser University’s 4D LABS, leveraging the expertise of materials scientists skilled in synthetic chemistry, polymer processing, and optics. The company aims to contribute to lower emissions and enhanced customer experiences in electric vehicle markets, as well as in custom solar management applications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.